Considering the importance of comparing the various selection strategies in relation to NAT tests and the absence of public studies on the topic, especially for the Brazilian reality,
the current bulletin presents some estimates on the residual risk reduction of HIV-1 and HCV virus transmission through blood. Regional blood donor incidence rates and the window
periods published in literature were used for these estimates.